- United Kingdom
- /
- Biotech
- /
- LSE:GNS
Exploring 3 High Growth Tech Stocks in the United Kingdom
Reviewed by Simply Wall St
The United Kingdom's FTSE 100 index recently closed lower, impacted by weak trade data from China, highlighting the interconnectedness of global markets. In this challenging environment, identifying high-growth tech stocks becomes crucial as they often offer resilience and potential for substantial returns amidst broader economic uncertainties.
Top 10 High Growth Tech Companies In The United Kingdom
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
STV Group | 13.15% | 46.78% | ★★★★★☆ |
Gaming Realms | 11.57% | 22.07% | ★★★★★☆ |
YouGov | 14.29% | 29.79% | ★★★★★☆ |
Facilities by ADF | 52.00% | 144.70% | ★★★★★☆ |
Redcentric | 4.89% | 63.79% | ★★★★★☆ |
Windar Photonics | 63.60% | 126.92% | ★★★★★☆ |
LungLife AI | 100.61% | 100.97% | ★★★★★☆ |
Beeks Financial Cloud Group | 24.63% | 57.95% | ★★★★★☆ |
Oxford Biomedica | 20.98% | 106.13% | ★★★★★☆ |
Vinanz | 113.60% | 125.86% | ★★★★★☆ |
Click here to see the full list of 47 stocks from our UK High Growth Tech and AI Stocks screener.
We're going to check out a few of the best picks from our screener tool.
Genus (LSE:GNS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Genus plc is an animal genetics company with operations spanning North America, Latin America, the United Kingdom, Europe, the Middle East, Russia, Africa, and Asia and has a market cap of £1.31 billion.
Operations: Genus plc generates revenue primarily through its Genus ABS and Genus PIC segments, contributing £314.90 million and £352.50 million respectively. The company operates globally, including regions such as North America, Latin America, the United Kingdom, Europe, the Middle East, Russia, Africa, and Asia.
Despite a challenging year marked by a significant one-off loss of £47.4M, Genus plc demonstrates resilience with its revenue growth forecast at 4.1% annually, outpacing the UK market's 3.7%. This growth is underpinned by an impressive projected annual earnings increase of 39.4%, significantly higher than the UK market average of 14.4%. However, it's crucial to note the decline in profit margins from last year's 4.8% to this year's 1.2%, reflecting some underlying challenges despite strong top-line growth forecasts and consistent dividend payments maintaining investor confidence. In terms of innovation and future readiness, Genus is not just resting on its laurels; the company is actively investing in research and development (R&D), which constitutes a substantial part of its strategy to stay ahead in biotechnology—a sector known for rapid evolution and technological dependency. The commitment to R&D not only helps in developing cutting-edge solutions but also strategically positions Genus to leverage scientific advancements for sustainable long-term growth.
- Take a closer look at Genus' potential here in our health report.
Evaluate Genus' historical performance by accessing our past performance report.
NCC Group (LSE:NCC)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: NCC Group plc operates in the cyber and software resilience sectors across the United Kingdom, Asia-Pacific, North America, and Europe with a market cap of £557.75 million.
Operations: NCC Group plc focuses on cyber and software resilience, generating £258.50 million from Cyber Security and £65.90 million from Escode. The company serves markets in the United Kingdom, Asia-Pacific, North America, and Europe.
NCC Group, amid a challenging market, is poised for notable growth with revenue expected to increase by 4.5% annually, outstripping the UK's average of 3.7%. This growth trajectory is complemented by an ambitious forecast in earnings, set to surge by 87.4% per year. The firm's commitment to innovation is evident in its R&D spending trends which are crucial for staying competitive in cybersecurity solutions—a sector where technological advancement is rapid and essential for maintaining client trust and operational integrity.
Sage Group (LSE:SGE)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: The Sage Group plc, along with its subsidiaries, offers technology solutions and services for small and medium businesses across the United States, the United Kingdom, France, and other international markets; it has a market cap of £10.22 billion.
Operations: Sage Group generates revenue primarily from Europe (£595 million), North America (£1.01 billion), and the United Kingdom & Ireland (£488 million). The company focuses on providing technology solutions and services tailored for small and medium businesses across these regions.
Sage Group, a stalwart in the UK tech scene, is navigating its growth trajectory with a keen focus on expanding its Sage Business Cloud portfolio. Recently, the company reported a 9% increase in quarterly revenue to £585 million, underscoring robust demand for cloud solutions. This performance aligns with their reaffirmed full-year guidance anticipating organic revenue growth mirroring the first half's pace around 9.3%. Strategic partnerships like that with VoPay are enhancing Sage's offerings; this collaboration integrates advanced payment technologies into Sage’s platforms, boosting efficiency for SMBs by replacing outdated manual processes with automated solutions. This move not only caters to current client needs but also positions Sage favorably within an increasingly competitive software market where seamless integration and security are paramount.
- Dive into the specifics of Sage Group here with our thorough health report.
Examine Sage Group's past performance report to understand how it has performed in the past.
Summing It All Up
- Unlock our comprehensive list of 47 UK High Growth Tech and AI Stocks by clicking here.
- Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
- Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.
Curious About Other Options?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About LSE:GNS
Genus
Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
Good value with reasonable growth potential.